Regenerative Medical Technology Group Inc.
For the period ended Dec 31, 2024. Filed Apr 15, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Apr 15, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 14. PRINCIPAL ACCOUNTING FEES AND SERVICES
| ITEM 14. | PRINCIPAL ACCOUNTING FEES AND SERVICES. |
|---|
Victor Mokuolu, CPA PLLC served as our independent registered public accountants for the year ended December 31, 2024, and for the year ended December 31, 2023.
Audit Fees
For the Company’s fiscal years ended December 31, 2024, and 2023, we were billed approximately $88,440 and $200,640, respectively, for professional services rendered by our independent auditors for the audit and review of our financial statements.
Audit Related Fees
There were no fees for audit related services rendered by our independent auditors for the years ended December 31, 2024, and 2023, respectively.
Tax Fees
For the Company’s fiscal years ended December 31, 2024, and 2023, there were no fees for professional services rendered by our independent auditors for tax compliance, tax advice, and tax planning.
All Other Fees
For the Company’s fiscal years ended December 31, 2024, and 2023, we were no billed any other fees by our auditors.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.